These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin. Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Lin ZY, Hou NJ, Hsieh MY, Wang LY, Yu ML. Antiviral Res; 2004 Oct; 64(1):47-53. PubMed ID: 15451178 [Abstract] [Full Text] [Related]
4. Association between SEN virus infection and hepatitis C in Japan. Umemura T, Alter HJ, Tanaka E, Yeo AE, Shih JW, Orii K, Matsumoto A, Yoshizawa K, Kiyosawa K. J Infect Dis; 2001 Nov 15; 184(10):1246-51. PubMed ID: 11679912 [Abstract] [Full Text] [Related]
5. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon. Nishizawa Y, Tanaka E, Orii K, Rokuhara A, Ichijo T, Yoshizawa K, Kiyosawa K. J Gastroenterol Hepatol; 2000 Nov 15; 15(11):1292-7. PubMed ID: 11129224 [Abstract] [Full Text] [Related]
7. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C. Karino Y, Toyota J, Sugawara M, Higashino K, Sato T, Ohmura T, Suga T, Okuuchi Y, Matsushima T. Am J Gastroenterol; 1997 Jan 15; 92(1):61-5. PubMed ID: 8995939 [Abstract] [Full Text] [Related]
8. SEN virus infection and its relationship to transfusion-associated hepatitis. Umemura T, Yeo AE, Sottini A, Moratto D, Tanaka Y, Wang RY, Shih JW, Donahue P, Primi D, Alter HJ. Hepatology; 2001 May 15; 33(5):1303-11. PubMed ID: 11343260 [Abstract] [Full Text] [Related]
9. SEN virus does not affect treatment response in hepatitis C virus coinfected patients but SEN virus response depends on SEN virus DNA concentration. Sagir A, Adams O, Kirschberg O, Erhardt A, Heintges T, Haussinger D. World J Gastroenterol; 2004 Jul 01; 10(13):1893-7. PubMed ID: 15222031 [Abstract] [Full Text] [Related]
11. Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan. Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. J Infect Dis; 2002 Feb 01; 185(3):389-92. PubMed ID: 11807722 [Abstract] [Full Text] [Related]
12. SEN virus prevalence among non-B and non-C hepatitis patients with high liver function tests in the south of Turkey. Serin MS, Koksal F, Oksuz M, Abayli B, Aslan G, Tezcan S, Yildiz C, Kayar B, Emekdas G. Jpn J Infect Dis; 2005 Dec 01; 58(6):349-52. PubMed ID: 16377865 [Abstract] [Full Text] [Related]
13. SEN Virus infection in HIV/HCV coinfected patients. Sagir A, Adams O, Oette M, Vogel M, Kupfer B, Emmelkamp J, Rockstroh J, Häussinger D. Eur J Med Res; 2008 Nov 24; 13(11):495-9. PubMed ID: 19073384 [Abstract] [Full Text] [Related]
14. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA. Transplant Proc; 2004 Nov 24; 36(6):1831-4. PubMed ID: 15350490 [Abstract] [Full Text] [Related]
16. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. Shibata M, Wang RY, Yoshiba M, Shih JW, Alter HJ, Mitamura K. J Infect Dis; 2001 Aug 15; 184(4):400-4. PubMed ID: 11471096 [Abstract] [Full Text] [Related]